Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

| Create an account https://orcid.org

Search life-sciences literature (45,103,589 articles, preprints and more)

Suggested authors matching "AUTH:Caux C" with an ORCID

Christophe Caux
INSERM
171
Publications
19,166
Citations
View profile

Search results

1-25 of 257 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.
Santagata S, Trotta AM, D'Alterio C, Napolitano M, Rea G, Di Napoli M, Portella L, Ieranò C, Guardascione G, Coppola E, Caux C, Dubois B, Boyle HJ, Carles J, Rossetti S, Azzaro R, Feroce F, Perdonà S, Fordellone M, [...] Scala S
Clin Cancer Res, 30(20):4755-4767, 01 Oct 2024
Cited by: 0 articles | PMID: 39167621 | PMCID: PMC11474171
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma.
Le Saux O, Ardin M, Berthet J, Barrin S, Bourhis M, Cinier J, Lounici Y, Treilleux I, Just PA, Bataillon G, Savoye AM, Mouret-Reynier MA, Coquan E, Derbel O, Jeay L, Bouizaguen S, Labidi-Galy I, Tabone-Eglinger S, Ferrari A, [...] Ray-Coquard I
Nat Commun, 15(1):5932, 16 Jul 2024
Cited by: 1 article | PMID: 39013886 | PMCID: PMC11252308
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Impact of TLR9 Expression Loss on Breast Cancer Tumor Cells
Sible E, Weitsman G, Amoyal S, Roblot G, Marotel M, Pescarmona R, Bendriss-Vermare N, Gillet C, Ceesay A, Michallet MC, Caux C, Cosset F, Al Alem U, Ng T, Hasan UA
bioRxiv, 06 Jul 2024
Cited by: 0 articles | PPR: PPR877914
Add to export list Preprint
Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients.
Dalle S, Verronese E, N'Kodia A, Bardin C, Rodriguez C, Andrieu T, Eberhardt A, Chemin G, Hasan U, Le-Bouar M, Caramel J, Amini-Adle M, Bendriss-Vermare N, Dubois B, Caux C, Ménétrier-Caux C
Oncoimmunology, 13(1):2372118, 26 Jun 2024
Cited by: 0 articles | PMID: 38939518 | PMCID: PMC11210932
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.
Lalle G, Lautraite R, Bouherrou K, Plaschka M, Pignata A, Voisin A, Twardowski J, Perrin-Niquet M, Stéphan P, Durget S, Tonon L, Ardin M, Degletagne C, Viari A, Belgarbi Dutron L, Davoust N, Postler TS, Zhao J, Caux C, [...] Grinberg-Bleyer Y
J Exp Med, 221(6):e20231348, 02 Apr 2024
Cited by: 0 articles | PMID: 38563819 | PMCID: PMC10986815
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features
Bendriss-Vermare N, Picant V, Revol-Bauz L, Tonon L, POUJOL D, Picard E, Rodriguez C, Degletagne C, Ferrari A, CAUX C
Research Square, 19 Mar 2024
Cited by: 0 articles | PPR: PPR824573
Add to export list Preprint v1
Spatial architecture of CD8⁺T cells and DC subsets is critical for the response to immune checkpoint inhibitors in melanoma
Gobbini E, Hubert M, Doffin A, Eberhardt A, Hermet L, Li D, Duplouye P, Barrin S, Berthet J, Benboubker V, Grimont M, Sakref C, Perrot J, Tondeur G, Harou O, Lopez J, Dubois B, Dalle S, Caux C, [...] Valladeau-Guilemond J
bioRxiv, 08 Feb 2024
Cited by: 0 articles | PPR: PPR804466
Add to export list Preprint
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Voissière A, Gomez-Roca C, Chabaud S, Rodriguez C, Nkodia A, Berthet J, Montane L, Bidaux AS, Treilleux I, Eberst L, Terret C, Korakis I, Garin G, Pérol D, Delord JP, Caux C, Dubois B, Ménétrier-Caux C, Bendriss-Vermare N, Cassier PA
Sci Transl Med, 16(731):eadd1834, 24 Jan 2024
Cited by: 9 articles | PMID: 38266104
Add to export list
[Cell therapy in all its forms].
Dougé A, Caux C, Bay JO
Bull Cancer, 111(2):213-221, 18 Jan 2024
Cited by: 0 articles | PMID: 38242769
Add to export list Review
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy
Saux OL, Sabatier R, Treilleux I, Renaud L, Brachet P, Martinez A, Frénel J, Abdeddaim C, Berthet J, Barrin S, Colombe-Vermorel A, Odeyer L, Lainé A, Caux C, Dubois B, Ray-Coquard I
Research Square, 10 Jan 2024
Cited by: 0 articles | PPR: PPR785519
Add to export list Preprint v1
MDR1-EXPRESSING CD4⁺ T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE.
Di Roio A, Hubert M, Besson L, Bossennec M, Rodriguez C, Grinberg-Bleyer Y, Lalle G, Moudombi L, Schneider R, Degletagne C, Treilleux I, Campbell DJ, Metzger S, Duhen T, Trédan O, Caux C, Ménétrier-Caux C
J Immunother Cancer, 11(11):e007733, 01 Nov 2023
Cited by: 4 articles | PMID: 37940345 | PMCID: PMC10632904
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes.
Coutant A, Cockenpot V, Muller L, Degletagne C, Pommier R, Tonon L, Ardin M, Michallet MC, Caux C, Laurent M, Morel AP, Saintigny P, Puisieux A, Ouzounova M, Martinez P
Lab Invest, 103(12):100258, 07 Oct 2023
Cited by: 4 articles | PMID: 37813278
Add to export list
IFN-III primes pDCs for TLR7 activation and antagonizes TGF-β mediated-immune suppression in tumors
valladeau-guilemond J, SAKREF C, SABY A, Rodriguez C, Ardin M, Moudombi L, DOFFIN A, GOBBINI E, VOISSIERE A, Besson L, LAOUBI L, Depil S, HUBERT M, Bendriss-Vermare N, CAUX C
Research Square, 01 Aug 2023
Cited by: 0 articles | PPR: PPR700939
Add to export list Preprint v1
Spatial transcriptomics reveal pitfalls and opportunities for the detection of rare high-plasticity breast cancer subtypes
Coutant A, Cockenpot V, Muller L, Degletagne C, Pommier R, Tonon L, Ardin M, Michallet M, Caux C, Laurent M, Morel A, Saintigny P, Puisieux A, Ouzounova M, Martinez P
bioRxiv, 28 Apr 2023
Cited by: 0 articles | PPR: PPR652090
Add to export list Preprint
[Tertiary lymphoid structures in cancer: From biology to therapeutic guides].
Quesada S, Lebreton C, Caux C, Italiano A, Dubois B
Bull Cancer, 110(6):657-664, 05 May 2023
Cited by: 0 articles | PMID: 37150731
Add to export list Review
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study.
Mery B, Ménétrier-Caux C, Montané L, Heudel PE, Ray-Coquard I, Bachelot T, Derbel O, Augereau P, Treilleux I, Berthet J, Nkodia A, Bardin-Dit-Courageot C, Attignon V, Ferrari A, Garin G, Perol D, Caux C, Dubois B, Trédan O
Breast Cancer (Dove Med Press), 15:311-325, 27 Apr 2023
Cited by: 0 articles | PMID: 37139242 | PMCID: PMC10150792
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Structural and Biochemical Characterization of Mycobacterium tuberculosis Zinc SufU-SufS Complex.
Elchennawi I, Carpentier P, Caux C, Ponge M, Ollagnier de Choudens S
Biomolecules, 13(5):732, 24 Apr 2023
Cited by: 6 articles | PMID: 37238602 | PMCID: PMC10216065
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The CSF-1R inhibitor Pexidartinib impacts dendritic cell differentiation through inhibition of FLT3 signaling and may antagonize the effect of durvalumab in patients with advanced cancer – results from a phase 1 study
Voissière A, Gomez-Roca C, Chabaud S, Rodriguez C, Nkodia A, Berthet J, Montane L, Bidaux A, Treilleux I, Eberst L, Terret C, Korakis I, Garin G, Pérol D, Delord J, Caux C, Dubois B, Ménétrier-Caux C, Bendriss-Vermare N, Cassier PA
medRxiv, 23 Feb 2023
Cited by: 0 articles | PPR: PPR620544
Add to export list Preprint
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.
Mangiante L, Alcala N, Sexton-Oates A, Di Genova A, Gonzalez-Perez A, Khandekar A, Bergstrom EN, Kim J, Liu X, Blazquez-Encinas R, Giacobi C, Le Stang N, Boyault S, Cuenin C, Tabone-Eglinger S, Damiola F, Voegele C, Ardin M, Michallet MC, [...] Fernandez-Cuesta L
Nat Genet, 55(4):607-618, 16 Mar 2023
Cited by: 17 articles | PMID: 36928603 | PMCID: PMC10101853
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CD4 T cells and neutrophils contribute to epithelial-mesenchymal transition in breast cancer
Sanlaville A, Voissière A, Poujol D, Hubert M, André S, Perret C, Foy J, Goutagny N, Malfroy M, Durand I, Châlons-Cottavoz M, Valladeau-Guilemond J, Saintigny P, Puisieux A, Caux C, Michallet M, Puisieux I, Bendriss-Vermare N
bioRxiv, 15 Feb 2023
Cited by: 0 articles | PPR: PPR617017
Add to export list Preprint
IL-33 drives polyfunctionality and antitumor activity of a unique ST2+ NK cell population
Eberhardt A, Blanc E, Picant V, Alcazer V, Rocca Y, Ardin M, Voissière A, Onodi F, Rodriguez C, Tonon L, Estavoyer B, Moudombi L, Charrier E, Wang X, Stojanovic A, Rau T, Tredan O, Treilleux I, Michallet M, [...] Bendriss-Vermare N
bioRxiv, 15 Feb 2023
Cited by: 0 articles | PPR: PPR616972
Add to export list Preprint
[A 2022 inventory in oncology news].
Bay JO, Bouleuc C, Caux C, Delom F, Firmin N, Gandemer V, L'Allemain G, Magné N, Orbach D, Robert J, Rodrigues M, Sabatier R, Thiery-Vuillemin A, Wislez M, Comité de rédaction du Bulletin du Cancer
Bull Cancer, 110(1):19-31, 16 Dec 2022
Cited by: 0 articles | PMID: 36529541
Add to export list Review
Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers.
Lounici Y, Le Saux O, Chemin G, Wajda P, Barrin S, Berthet J, Caux C, Dubois B
Cancers (Basel), 14(19):4800, 30 Sep 2022
Cited by: 0 articles | PMID: 36230721 | PMCID: PMC9563085
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors.
Foy JP, Karabajakian A, Ortiz-Cuaran S, Boussageon M, Michon L, Bouaoud J, Fekiri D, Robert M, Baffert KA, Hervé G, Quilhot P, Attignon V, Girod A, Chaine A, Benassarou M, Zrounba P, Caux C, Ghiringhelli F, Lantuejoul S, [...] Saintigny P
Data Brief, 44:108556, 27 Aug 2022
Cited by: 7 articles | PMID: 36111282 | PMCID: PMC9467865
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients.
Foy JP, Karabajakian A, Ortiz-Cuaran S, Boussageon M, Michon L, Bouaoud J, Fekiri D, Robert M, Baffert KA, Hervé G, Quilhot P, Attignon V, Girod A, Chaine A, Benassarou M, Zrounba P, Caux C, Ghiringhelli F, Lantuejoul S, [...] Saintigny P
Eur J Cancer, 174:287-298, 26 Aug 2022
Cited by: 14 articles | PMID: 36038492
Add to export list

1-25 of 257 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Suggested authors matching "AUTH:Caux C" with an ORCID

Search results

KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.

Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma.

The Impact of TLR9 Expression Loss on Breast Cancer Tumor Cells

Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients.

NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.

Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features

Spatial architecture of CD8⁺T cells and DC subsets is critical for the response to immune checkpoint inhibitors in melanoma

The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.

[Cell therapy in all its forms].

Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy

MDR1-EXPRESSING CD4⁺ T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE.

Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes.

IFN-III primes pDCs for TLR7 activation and antagonizes TGF-β mediated-immune suppression in tumors

Spatial transcriptomics reveal pitfalls and opportunities for the detection of rare high-plasticity breast cancer subtypes

[Tertiary lymphoid structures in cancer: From biology to therapeutic guides].

Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study.

Structural and Biochemical Characterization of Mycobacterium tuberculosis Zinc SufU-SufS Complex.

The CSF-1R inhibitor Pexidartinib impacts dendritic cell differentiation through inhibition of FLT3 signaling and may antagonize the effect of durvalumab in patients with advanced cancer – results from a phase 1 study

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.

CD4 T cells and neutrophils contribute to epithelial-mesenchymal transition in breast cancer

IL-33 drives polyfunctionality and antitumor activity of a unique ST2+ NK cell population

[A 2022 inventory in oncology news].

Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers.

Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors.

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients.

Partnerships & funding

Search life-sciences literature (45,103,589 articles, preprints and more)

Suggested authors matching "AUTH:Caux C" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Caux C" with an ORCID